02.21.24
Cepham, an ingredient supplier specializing in ayurvedic nutraceuticals, has expanded its healthy aging line to include two new ingredients formulated to clear senescent cells.
Senescent cells are colloquially known as “zombie cells,” due to their lingering presence in the body which can lead to detrimental effects on surrounding cells. Over time, it’s thought the accumulation of senescent cells, which is related to the aging process, may contribute to various age-related health conditions.
Senolytics are compounds designed to target and eliminate senescent cells from the body, promote tissue regeneration, and reduce inflammation.
“Cepham’s decision to include senolytics in its Sustainable Aging ingredient offerings reflects our company's commitment to delivering affordable, high-quality, evidence-based, and safe ingredients to customers,” says Christopher Lamb, vice president of commercial strategy at Cepham. “The senolytic agents selected by Cepham have undergone rigorous testing to ensure they meet the highest standards of safety and efficacy.”
The new plant-based products will be inspired by the principles of Ayurveda and Traditional Chinese Medicine (TCM). The company will extensively research its ingredients on cellular and molecular levels, ensure safety in animal studies, and confirm efficacy in human clinical trials, with plans to publish the results of its ongoing research in the coming months.
“As the importance of aging as a health concern grows, we anticipate a surge in companies entering or expanding their offerings in healthy aging products to meet this demand. We are committed to empowering them to do so confidently,” said Lamb. “By embracing the science behind senolytics, Cepham is equipping companies with quality options for longevity supplements backed by science.”
Cepham’s products in its sustainable aging line will target mitochondrial, metabolic, and cellular aging, neuroprotection, hair and skin aging, microbiome health, DNA stability, and mitigating a number of cellular aging markers like telomere shohrtening, cellular signaling, and autophagy.
Senescent cells are colloquially known as “zombie cells,” due to their lingering presence in the body which can lead to detrimental effects on surrounding cells. Over time, it’s thought the accumulation of senescent cells, which is related to the aging process, may contribute to various age-related health conditions.
Senolytics are compounds designed to target and eliminate senescent cells from the body, promote tissue regeneration, and reduce inflammation.
“Cepham’s decision to include senolytics in its Sustainable Aging ingredient offerings reflects our company's commitment to delivering affordable, high-quality, evidence-based, and safe ingredients to customers,” says Christopher Lamb, vice president of commercial strategy at Cepham. “The senolytic agents selected by Cepham have undergone rigorous testing to ensure they meet the highest standards of safety and efficacy.”
The new plant-based products will be inspired by the principles of Ayurveda and Traditional Chinese Medicine (TCM). The company will extensively research its ingredients on cellular and molecular levels, ensure safety in animal studies, and confirm efficacy in human clinical trials, with plans to publish the results of its ongoing research in the coming months.
“As the importance of aging as a health concern grows, we anticipate a surge in companies entering or expanding their offerings in healthy aging products to meet this demand. We are committed to empowering them to do so confidently,” said Lamb. “By embracing the science behind senolytics, Cepham is equipping companies with quality options for longevity supplements backed by science.”
Cepham’s products in its sustainable aging line will target mitochondrial, metabolic, and cellular aging, neuroprotection, hair and skin aging, microbiome health, DNA stability, and mitigating a number of cellular aging markers like telomere shohrtening, cellular signaling, and autophagy.
